2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Role of ATP10B variants in Parkinson Disease in a southern Spanish cohort

R. Díaz-Belloso, MT. Periñan, M. Martín-Bornez, S. García-Díaz, M. Bonilla-Toribio, D. Buiza-Rueda, R. Pineda-Sánchez, L. Muñoz-Delgado, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, P. Mir, P. Gómez-Garre (Sevilla, Spain)
Role of bilateral pallidotomy in status dystonicus

K. Garg, M. Singh, R. Rajan (New Delhi, India)
Role of nanoparticles of berberine on oxidative stress in nigrostriatal tissue and neurobehavioral characteristics in rotenone induced animal model of Parkinson’s disease

R. Rajput, V. Sharma (New Delhi, India)
Role of the direct subthalamo-cerebellar tract in memory and learning: Implications for the pathophysiology of late-stage Parkinson’s Disease

V. Radhakrishnan, C. Gallea, S. Krishnan, B. Thomas, C. Kesavadas, A. Kishore (Trivandrum, India)
RT-QuIC for detection of pathological α-synuclein in the olfactory mucosa and CSF of Parkinson’s disease patients

V. Tommasini, M. Bongianni, M. Catalan, D. Perra, P. Polverino, C. Bertolotti, R. Baruca, G. Bellavita, L. Antonutti, G. Zanusso, P. Manganotti (Trieste, Italy)
Sacral Mass Lesion Mimicking Atypical Foot Dystonia In Parkinsonian Patient

B. Barton (CHICAGO, USA)
SAFE-DBS – A monocentric, randomised, blind evaluation of safinamide in the perioperative period in Parkinsonian patients with deep brain stimulation

E. Gülke, M. Höfs, H. Pinnschmidt, A. Gulberti, C. Moll, U. Hidding, C. Buhmann, M. Heise, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)
Safety and efficacy of focused ultrasound thalamotomy in essential tremor: a real scenario within the public health system.

D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. González, R. álvarez (badalona, Spain)
Safety and efficacy of P2B001 (low dose combination of extended-release pramipexole and rasagiline) in patients with early Parkinson’s disease: Subgroup analyses from a randomized, controlled trial

D. Falconer, P. Litman, H. Friedman, S. Oren, C. Fitter-Attas (Alexandria, USA)
Safety and performance of DBS primary cell IPG replacement: An interim report from the ADROIT study

S. Groppa, J. Muñoz, K. Ashkan, A. Gharabaghi, T. Tomlinson, M. Frassica, M. Navas Garcia (Mainz, Germany)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z